Helius Medical Technologies is trading 6.84% up at $2.50 after no new company-specific announcement was identified for August 31, 2026.

  • The latest official investor-relations releases, dated August 21 and August 14, covered Solana governance positions and second-quarter results.
  • The move appears speculative and follows substantial recent volatility: an 18.54% gain on August 27 and a 3.70% decline on August 28.
  • Broader U.S. futures are modestly lower, so market direction does not clearly explain this pre-market gain.